Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
LY2452473
DRUG
4 trials
Sponsors
Eli Lilly and Company
, Dana-Farber Cancer Institute
Conditions
Erectile Dysfunction
Healthy Volunteers
Prostate Cancer
Phase 1
Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects
Completed
NCT01275157
Eli Lilly and Company
Healthy Volunteers
Start: 2011-01-31
End: 2011-02-28
Updated: 2011-04-15
A Bioavailability Study of LY2452473 and Tadalafil
Completed
NCT01401543
Eli Lilly and Company
Erectile Dysfunction
Start: 2011-07-31
End: 2011-09-30
Updated: 2019-06-14
Phase 2
A Study of LY900010 in Erectile Dysfunction
Completed
NCT01160289
Eli Lilly and Company
Erectile Dysfunction
Start: 2010-10-31
End: 2011-11-30
Updated: 2019-04-09
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Completed
NCT02499497
Dana-Farber Cancer Institute
Prostate Cancer
Start: 2016-02-29
End: 2020-10-31
Updated: 2021-09-28